Join
Live feed
·
INSIDERFilingvia Quantisnow
Revance Therapeutics Inc. logo

New insider Hollander David claimed ownership of 108,853 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
RVNC· Revance Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RVNC (Revance Therapeutics Inc.) and more on Quantisnow.